Featured in LiveMint- Zomato IPO
"With the improved sentiments in primary and broader market I expect Zomato may list in three digits. Zomato's listing will set a benchmark for upcoming start up IPOs," said Abhay Doshi, founder of UnlistedArena.com.
Featured in LiveMInt- Zomato Listing
Speaking on the possible Zomato IPO listing gains; Abhay Doshi, founder of UnlistedArena.com said, "With the improved sentiments in primary and broader market, I expect Zomato may list in three digits. Zomato's listing will set a benchmark for upcoming start up IPOs."
Featured in Hindustan Times- Zomato Listing
"With the improved sentiments in the primary and broader market, I expect Zomato may list in three digits. Zomato's listing will set a benchmark for upcoming startup IPOs," Abhay Doshi, founder of UnlistedArena.com, was quoted as saying by Mint Live.
Featured in Financial Express- Glenmark Life Sciences IPO
“One must not depend on grey premium as a sole indicator and concentrate more on the financials of the company,” Abhay Doshi, Cofounder of UnlistedArena, a firm dealing in unlisted & pre-IPO shares, told Financial Express Online. He said that the Indian API industry is witnessing an upper growth trajectory due to supportive government policies, low production cost base, and China +1 strategy. Also, stricter control on Chinese API companies should be fruitful for Indian companies.
On the financial front, at the upper price of Rs 720, the issue is priced at 22x to its earnings. “Compared to its peers, the issue looks moderately priced. However, the expansion plans in API and CDMO segment should capture the market share going ahead,” Doshi added.
Featured in Economic Times- Recent IPO Market Scenario
“Following the buzz in primary market, even the grey market is over-valuing the IPO-bound companies,” said Abhay Doshi, founder, UnlistedArena. “Investors should ignore the grey market premium while subscribing to IPOs.”
The better-than-expected listings of Zomato, GR Infra and Clean Science in the previous week have added fuel to the fire. “At such a hefty premium, apparently, the unofficial market is ignoring the fundamentals,”
Featured in Economic Times- Tatva Chintan Pharma Listing
"A strong listing for Tatva Chintan looks on the cards, thanks to its small issue size and a ruboff from the recent solid listings and also because of the fact not all investors who wanted to invest in the issue would get allotment due to huge response to the issue," said Abhay Doshi, founder at UnlistedArena.com
Featured in Economic Times- GR Infra and Clean Science IPO Listings
"The signals are sturdy enough for healthy listing gains. Both GR Infra and Clean Science issues were heavily oversubscribed and left something on the table for investors," said Abhay Doshi, Founder, UnlistedArena.com.
He said the companies are fundamentally sound, which is adding to the optimism. "Stocks of the recently listed companies have witnessed a sharp rise, which has further boosted the sentiment," he said.
Featured in Economic Times- Tatva Chintan Pharma IPO
Abhay Doshi, Founder, Unlisted Area, said the company is a leader in the niche chemical segment, which is export oriented.
Featured in Money9- Rolex Rings IPO
“Glaring at the performance of the company the growth seems to be missing as revenue from operations remained at Rs 616.33 crore in FY 2020-21 from Rs 904.3 crore in FY 2019. As per RHP the company had defaulted in payment of certain loans in the past, and had approached CDR Cell for restructuring debt in FY 2013,” said the founder of Unlisted Arena, Abhay Doshi.
The raw materials used by the company pre-dominantly include carbon steel, alloy steel and stainless steel, the price of which has been volatile in the past which could affect their operating margins.
At the price of Rs 900, the asking PE comes at 24x. High sentiment in primary markets may emanate in listing gains but for the long term, it would be worthy to watch for future performance and take any decision, added Doshi.
Featured in Money9- Glenmark Life Sciences IPO
“The Indian API industry is witnessing upper growth trajectory due to supportive government policies, low production cost base, China +1 strategy. Also, the stricter control on Chinese API companies should be fruitful for Indian companies,” told Abhay Doshi, Founder, Unlisted Arena.